| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fortrea Holdings Inc. | General Counsel | Restricted Stock Unit | 47,167 | $588,412 | $9.70 | 08 Sep 2025 | Direct |
| G1 Therapeutics, Inc. | General Counsel | Common Stock | 41,087 | $120,890 | $2.94 | 05 Jan 2023 | Direct |
| Fortrea Holdings Inc. | General Counsel | Common Stock | 14,981 | $62,470 | $4.17 | 03 Jun 2025 | Direct |
| G1 Therapeutics, Inc. | General Counsel | Stock Options (Right to buy) | 35,700 | 03 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FTRE | Fortrea Holdings Inc. | 08 Sep 2025 | 3 | -$17,156 | 4 | General Counsel | 10 Sep 2025, 16:34 |
| FTRE | Fortrea Holdings Inc. | 02 Jun 2025 | 3 | -$9,136 | 4 | General Counsel | 04 Jun 2025, 17:42 |
| FTRE | Fortrea Holdings Inc. | 13 Mar 2025 | 3 | -$9,768 | 4 | General Counsel | 17 Mar 2025, 16:37 |
| FTRE | Fortrea Holdings Inc. | 06 Mar 2025 | 2 | $0 | 4 | General Counsel | 10 Mar 2025, 17:08 |
| FTRE | Fortrea Holdings Inc. | 12 Jun 2024 | 1 | +$50,600 | 4 | General Counsel | 12 Jun 2024, 18:28 |
| FTRE | Fortrea Holdings Inc. | 03 Jun 2024 | 3 | -$55,440 | 4 | General Counsel | 03 Jun 2024, 19:08 |
| FTRE | Fortrea Holdings Inc. | 13 Mar 2024 | 1 | $0 | 4 | General Counsel | 15 Mar 2024, 16:51 |
| FTRE | Fortrea Holdings Inc. | 30 Jun 2023 | 1 | $0 | 4/A | General Counsel | 19 Jul 2023, 17:02 |
| FTRE | Fortrea Holdings Inc. | 20 Jun 2023 | 1 | $0 | 4 | General Counsel | 21 Jun 2023, 16:34 |
| FTRE | Fortrea Holdings Inc. | 09 Jun 2023 | 0 | $0 | 3 | General Counsel | 09 Jun 2023, 17:49 |
| /report/000156218023000250-hanson-james-s-2023-01-03 | G1 Therapeutics, Inc. | 03 Jan 2023 | 4 | -$13,080 | 4 | General Counsel | 05 Jan 2023, 19:25 |
| /report/000156218022000309-hanson-james-s-2022-01-03 | G1 Therapeutics, Inc. | 03 Jan 2022 | 3 | -$15,334 | 4 | General Counsel | 05 Jan 2022, 19:48 |